# NSN 6505-00-138-8461: Phenazopyridine Hydrochloride Ta

NSN 6505-00-138-8461 (also written 6505001388461; NIIN 00-138-8461) is a phenazopyridine hydrochloride ta in Federal Supply Class 6505, Drugs and Biologicals. 9 manufacturer part numbers from 7 suppliers are on record. It was last purchased in Sep 2026.

## Identification

- NSN: 6505-00-138-8461 (6505001388461)
- NIIN: 00-138-8461 (001388461)
- Item name: PHENAZOPYRIDINE HYDROCHLORIDE TA
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC Z: a commercial, nondevelopmental or off-the-shelf item. (observed 2026-10-10)
- Acquisition method code: 1

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEAT | SPECIAL FEATURES | STORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 C (68 TO 77 F) EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) SEE USP CONTROLLED ROOM TEMPERATURE. |
| SUPP | SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS USP 100 MG 100 TABLETS BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS PHENAZOPYRIDINE HYDROCHLORIDE ACTIVE INGREDIENT 100.000 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| NDC42937-0701-10 | 61RJ6 | UNITED DRUG SUPPLY INC DBA UNITED DRUG SUPPLY INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC42937-0701-10 | 660P4 | BI COASTAL PHARMACEUTICAL | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC51293-0810-01 | 7AMD3 | ECI PHARMACEUTICALS LLC DBA ECI PHARMACEUTICALS | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC58657-0450-01 | 74XY7 | METHOD PHARMACEUTICALS, LLC DBA METHOD PHARMACEUTICALS LLC DIV METHOD PHARMACEUTICALS | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC60846-0501-01 | 7AN71 | GEMINI LABORATORIES LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC65162-0681-10 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC75826-0114-10 | 00E55 | CARDINAL HEALTH, INC. | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| PYRIDIUM | 7AN71 | GEMINI LABORATORIES LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| PYRIDIUM 100MG 100S | 7AN71 | GEMINI LABORATORIES LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F028M](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461) | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS | DMS PHARMACEUTICAL GROUP INC | $452.30 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F019U](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461) | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS | DMS PHARMACEUTICAL GROUP INC | $452.30 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F020P](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461) | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS | DMS PHARMACEUTICAL GROUP INC | $452.30 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F018P](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461) | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS | DMS PHARMACEUTICAL GROUP INC | $452.30 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F006D](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461) | PHENAZOPYRIDINE HYDROCHLORIDE TABLETS | DMS PHARMACEUTICAL GROUP INC | $904.60 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505001388461&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505001388461
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-00-138-8461/
JSON: https://nsnexplorer.com/api/nsn/6505-00-138-8461.json